论文部分内容阅读
目的:对莫沙必利联合胃复春与单药应用治疗功能性消化不良的临床疗效进行对比分析。方法:采用随机抽选法从本院2013年12月~2016年12月收治的功能性消化不良患者中抽取40例作为研究对象,其中采用单纯莫沙必利治疗的20例患者分为对照组,采用莫沙必利联合胃复春治疗的20例患者分为观察组,对两组患者疗效进行对比分析。结果:治疗后观察组患者的总有效率显著比对照组高(p<0.05),经过半年随访观察组患者的复发率也显著比对照组低(p<0.05)。结论:临床治疗功能性消化不良可采用莫沙必利联合胃复春治疗,其疗效确切,且能有效降低复发率,未有明显不良反应发生,具有较高的临床应用价值。
Objective: To compare and analyze the clinical curative effect of Mosapride combined with Weifuchun and single drug in the treatment of functional dyspepsia. Methods: Forty patients with functional dyspepsia admitted from December 2013 to December 2016 in our hospital were randomly divided into two groups: control group (20 cases) , 20 patients treated with mosapride combined with Wei Fuchun were divided into observation group and comparative analysis of the curative effect of the two groups of patients. Results: After treatment, the total effective rate of the observation group was significantly higher than that of the control group (p <0.05). The relapse rate of the observation group after 6 months follow-up was significantly lower than that of the control group (p <0.05). Conclusion: Clinical treatment of functional dyspepsia can be treated with Mosapride combined with Weifuchun, its curative effect is exact, and can effectively reduce the recurrence rate, no obvious adverse reactions, with high clinical value.